AstraZeneca hires, Pfizer restructures
Senior in-house moves dominate this week's newsletter, with Rikki Jones joining AstraZeneca and Pfizer dispersing its corporate affairs team.
Newsletter
Ruder Finn bets on local depth with ERA acquisition
Long reliant on China, Ruder Finn’s Southeast Asia deal challenges ‘helicopter’ PR models — favouring local expertise in often-overlooked markets.
Emily Poon to depart Ogilvy PR
This week's newsletter also features a podcast with Richard Edelman.
Plus ça change? 🦁
This year’s PR Lions prompts familiar questions about agency recognition and new ones about how different perspectives are heard.
Cannes in context 🦁
After a watershed year, the hope is for more substantive progress and less angst from the PR community at Cannes.
Why Asian PR firms are eyeing IPOs
A handful of Asian PR firms are preparing to go public. Will their efforts reshape the industry's growth model?
The unlikely case for integration
The pragmatic progress of MSL and Ogilvy PR challenge long-held assumptions about PR firm relevance within holding groups.